Vienna Insurance Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.27M | Hold |
|
|||||
|
2025
Q2 | $3.82M | Hold |
|
|||||
|
2025
Q1 | $3.36M | Hold |
|
|||||
|
2024
Q4 | $4.15M | Hold |
|
|||||
|
2024
Q3 | $3.5M | Hold |
|
|||||
|
2024
Q2 | $4.19M | Hold |
|
|||||
|
2024
Q1 | $4.19M | Hold |
|
|||||
|
2023
Q4 | $4.01M | Hold |
|
|||||
|
2023
Q3 | $3.42M | Hold |
|
|||||
|
2023
Q2 | $2.87M | Hold |
|
|||||
|
2023
Q1 | $3.08M | Sell |
|
|||||
|
2022
Q4 | $5.42M | Hold |
|
|||||
|
2022
Q3 | $4.82M | Hold |
|
|||||
|
2022
Q2 | $4.43M | Hold |
|
|||||
|
2022
Q1 | $4.26M | Hold |
|
|||||
|
2021
Q4 | $3.87M | Hold |
|
|||||
|
2021
Q3 | $4.35M | Hold |
|
|||||
|
2021
Q2 | $4.42M | Buy |
|
|||||
|
2021
Q1 | $3.01M | Buy |
|